A device to diagnose and monitor acute respiratory distress syndrome using breath analysis
Point-of-care micro-gas chromatography device for diagnosis and monitoring of acute respiratory distress syndrome using exhaled breath signatures
This study is testing a small, portable device that can analyze your breath to help doctors diagnose and keep track of acute respiratory distress syndrome (ARDS) by looking for specific chemicals in your breath.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-11004101 on NIH RePORTER |
What this research studies
This research focuses on developing a portable micro-gas chromatography device that can analyze exhaled breath to diagnose and monitor acute respiratory distress syndrome (ARDS). By capturing volatile organic compounds (VOCs) and inorganic compounds (VICs) from the breath, the device aims to identify specific patterns that indicate the presence of ARDS and track its progression over time. The research involves validating initial findings from a small group of patients and gathering extensive data to refine the device's accuracy and effectiveness in clinical settings.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults over 21 years old who are experiencing acute respiratory distress or related conditions.
Not a fit: Patients with chronic respiratory conditions or those under 21 years old may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to a non-invasive method for early diagnosis and continuous monitoring of ARDS, potentially improving patient outcomes.
How similar studies have performed: Previous research has shown promise in using breath analysis for diagnosing respiratory conditions, suggesting that this approach could be effective.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Fan, Xudong — University of Michigan at Ann Arbor
- Study coordinator: Fan, Xudong
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.